Mitoxanthrone
Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .
Mitoxanthrone. Mitoxanthrone is an immunomodulator and immunosuppressant. Fully referenced neurology checklist.
Mode of action
- Mitoxanthrone is an immunomodulator and immunosuppressant
Dosing
Locked: subscribe to see this section.
Side effects
Locked: subscribe to see this section.
Contraindications
Locked: subscribe to see this section.
Echocardiogram monitoring
Locked: subscribe to see this section.
Other monitoring
Locked: subscribe to see this section.
References
- Torkildsen Ø, Myhr KM, Bø L. Disease-modifying treatments for multiple sclerosis – a review of approved medications. Eur J Neurol 2016; 23(Suppl 1):18-27.
- Rice CM. Disease modification in multiple sclerosis: an update. Pract Neurol 2014; 14:6-13.
- Dargahi N, Katsara M, Tselios T, et al. Multiple sclerosis: immunopathology and treatment update. Brain Sci 2017; 7(7) pii: E78.
- Wingerchuk DM, Weinshenker BG. Disease modifying therapies for relapsing multiple sclerosis. BMJ 2016; 354:i3518.
- Vargas DL, Tyor WR. Update on disease-modifying therapies for multiple sclerosis. J Investig Med 2017; 65:883-891.
- And 1 more. Subscribe to see the full list
